All News about BeiGene, Ltd. - American Depositary Shares




A Glimpse Into The Expert Outlook On BeiGene Through 4 Analysts
December 03, 2024
Via Benzinga


BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor
December 12, 2024
From BeiGene, Ltd.
Via Business Wire



Expert Outlook: BeiGene Through The Eyes Of 4 Analysts
October 22, 2024
Via Benzinga



BeiGene to Present at Upcoming Investor Conferences
November 26, 2024
From BeiGene, Ltd.
Via Business Wire

What Analysts Are Saying About BeiGene Stock
September 18, 2024
Via Benzinga

From BeiGene, Ltd.
Via Business Wire


From BeiGene, Ltd.
Via Business Wire

BeiGene to Present at the Jefferies London Healthcare Conference
November 06, 2024
From BeiGene, Ltd.
Via Business Wire

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
November 05, 2024
From BeiGene, Ltd.
Via Business Wire

BeiGene Mourns Death of Beloved Board Member Donald Glazer
October 28, 2024
From BeiGene, Ltd.
Via Business Wire


From BeiGene, Ltd.
Via Business Wire

Via Benzinga



From BeiGene, Ltd.
Via Business Wire

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Via Benzinga
Exposures
Product Safety




BeiGene Announces Updates to Commercial Leadership Team
September 09, 2024
From BeiGene, Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.